Adenosine-dopamine interactions in the brain

Neuroscience

Volumn 51, Issue 3, 1992, Pages 501-512

  Ferre S ^a   Fuxe, K ^b   von Euler, G ^b   Johansson, B ^b   Fredholm, B B ^b  

^a DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 ANILINOADENOSINE; 8 PHENYLTHEOPHYLLINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; DOPAMINE RECEPTOR; PHENYLISOPROPYLADENOSINE; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BEHAVIOR; CORPUS STRIATUM; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ADENOSINE; ANIMAL; BRAIN CHEMISTRY; DOPAMINE; HUMAN; RECEPTORS, DOPAMINE D2; RECEPTORS, PURINERGIC; SUPPORT, NON-U.S. GOV'T;

EID: 0026454971     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(92)90291-9     Document Type: Article

References (116)

1. Subcortical limbic 3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8in vitro
2. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites
3. The functional anatomy of basal ganglia disorders
4. Functional architecture and basal ganglia circuits: neural substrates of parallel processing
5. The cellular localization of adenosine receptors in rat neostriatum
6. Functional role of the nigrostriatal dopamine neurons
7. Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat
8. Action de la caffeine sur la motilitée spontanée de la souris
9. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain
10. 2 receptor and choline acetyl transferase mRNA in the dopamine deafferented rat caudate-putamen
11. The search for purine and ribose-substituted adenosine analogs with potential clinical application
12. Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action
13. Striatal A2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation
14. 3H-NECA in rat striatal membranes
15. Adenosine antagonists as pharmacological tools
16. Cloning and expression of a rat D2 dopamine receptor cDNA
17. Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway
18. Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors
19. Presynaptic adenosine A2 and N-methyl-spd-aspartate receptors regulate dopamine synthesis in rat striatal synaptosomes
20. Effects of selected analogs of adenosine on schedule controlled behaviour in rats
21. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons
22. Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines
23. Analogs of caffeine and theophylline: activity as antagonists at adenosine receptors
24. Primate models of movement disorders of basal ganglia origin
25. The physiological role of adenosine in the central nervous system
26. NECA-induced hypomotility in mice: evidence for a predominantly central site of action
27. Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice
28. Prospective role for adenosine and adenosinergic systems in psychiatric disorders (Editorial)
29. Phosphorylation by cyclic AMP-dependent protein kinase modulates agonist binding to the D2 dopamine receptor
30. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels and response to caffeine
31. 2 receptors in rat striatal membranes
32. 2 agonist binding sites in rat neostriatal membranes
33. The distribution of adenosine A1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals
34. 3H]SCH 23390 from rat striatal membranes
35. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit a D-2 mediated behaviour in short-term reserpinized mice
36. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice
37. 2 receptors induces catalepsy
38. Stimulation of high affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in rat striatal membranes
39. 2 receptors in the neostriatum
40. Effect of some phosphodiesterase inhibitors on central dopamine mechanisms
41. Activation of adenylate cyclase from rat striatum and tuberculum olfactorium by adenosine
42. Modulation of neurotransmission by purine nucleotides and nucleosides
43. Are methylxanthine effects due to antagonism of endogenous adenosine?
44. On the mechanisms by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat
45. Adenosine and central catecholamine neurotransmission
46. Formation and actions of adenosine in the rat hippocampus, with special reference to the interactions with classical transmitters
47. Interactions of the bovine brain A1-adenosine receptor and recombinant G protein α-subunits. Selectivity for rGiα-3
48. Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with I-dopa and dopamine agonists
49. 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites
50. 3H-N-propylnorapomorphine binding sites in striatal membranes
51. Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses
52. 2 transmission lines in the central nervous system
53. D1 and D2 dopamine receptor-regulated gene expression of strionigral and striopallidal neurons
54. 6-(L-phenylisopropyl) adenosine and their combination in the squirrel monkey
55. Anxiety or caffeinism: a diagnostic dilemma
56. Modulation of striatal dopaminergic function by local injection of 5′-N-ethylcarboxamide adenosine
57. Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX
58. Behavioural effects of selective A2 adenosine receptor antagonists, CGS 21197 and CGS 22706, in mice
59. Reinforcing effects of caffeine in humans
60. Reinforcing properties of caffeine: studies in humans and laboratory animals
61. Effects of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum
62. Comparison of the behavioural effects of adenosine agonists and dopamine antagonists in mice
63. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses
64. 2 selective adenosine receptor agonist with preferential hypotensive activity
65. 2 receptors in the rat brain
66. 2 receptors in rat brain
67. 2 receptors in the rat brain
68. Adenosine in central nervous system function
69. Behavioural effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine
70. The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?
71. Dopamine receptor gene expression by enkephalin neurons in rat forebrain
72. 2 dopamine receptor gene expression by cholinergic neurons in the rat striatum
73. 1 dopamine receptor gene
74. The psychobiology of neurotensin
75. Selective amplification and cloning of four new members of the G-protein-coupled receptor family
76. Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor
77. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum
78. 2 receptor with physiological constitutive activity
79. Adenosine stimulates glycogenolysis in mouse cerebral cortex: a possible coupling mechanism between neuronal activity and energy metabolism
80. Basal ganglia disease
81. Huntington's disease: new approaches to an old problem
82. Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease
83. The effects of caffeine, theophylline and amphetamine on operand responding of the mouse
84. Adenosine modulation of synaptosomal dopamine release
85. Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry
86. Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat
87. Decrease in rat striatal dopamine synthesis and metabolism in vivo by metabolically stable adenosine receptor agonists
88. Adenosinergic modulation of caffeine-induced c-fos mRNA expression in mouse brain
89. Characterization of the locomotor depression produced by an A2-selective adenosine agonist
90. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes
91. Characterization of dopamine receptors mediating inhibition of adenylyl cyclase activity in rat striatum
92. 3H]-CGS 21680 as a ligand
93. Adenosine-sensitive adenylate cyclase in rat brain homogenates: kinetic characteristics, specificity, topographical, subcellular and cellular distribution
94. Effects of adenosine on adenylate cyclase in broken cell preparations of central nervous system
95. Evolution of the mechanisms of action of methylxanthines from calcium mobilizers to antagonists of adenosine receptors
96. 45Ca uptake by synaptosomes stimulated by potassium
97. The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′, 5′phosphate content of guinea pig cerebral cortex slices
98. (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study
99. Adenosine receptors and behavioural actions of methylxanthines
100. Adenosine as a neuromodulator
101. 2 receptors
102. Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism
103. Effects of caffeine and theophylline on activity of rats in relation to brain xanthine concentrations
104. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigrostriatal dopamine system in the rat brain
105. Behavioural pharmacology of dopamine receptor mechanisms
106. 2 receptors
107. Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells
108. Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA)
109. Sensitization by caffeine of central catecholamine receptors
110. 3H]SCH 39166
111. Monoamine synthesis and caffeine-induced locomotor activity
112. Brain adenosine production in rat during sustained-alteration in systemic blood pressure
113. Brain adenosine concentration during hypoxia in rats
114. Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation
115. Neuropharmacological profile of cholecystokinin-like peptides
116. Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre